HealthEquity, Inc.
- Jurisdiction
United States - LEI
529900LRJU1RAFQHM467 - ISIN
US42226A1079 (HQY )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€75.66 2.4% overvalued - Financial strength (Piotroski F-Value)
-
8
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. Read full profile
Fundamentals
- Net revenue
€1.08B - Gross margin
66.4% - EBIT
€199.99M - EBIT margin
18.5% - Net income
€124.39M - Net margin
11.5%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
| Gilbert Cisneros | July 10, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | February 13, 2025 | $1.00K–$15.00K |
| Josh Gottheimer | December 5, 2024 | $1.00K–$15.00K |
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Sell |